SCHEMBL30860764

SCHEMBL30860764

COc1cc(N2CCC(N3CCN(C)CC3)CC2)c(Cl)cc1Nc1ncc(Br)c(Nc2cc3c(cc2P(C)C)CCO3)n1

nearest known ligand 0.55

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ EGFR P00533 15/20 0.55
▸ INSR P06213 5/20 0.49
▸ IGF1R P08069 5/20 0.49
▸ ALK Q9UM73 5/20 0.49
▸ CHEK1 O14757 1/20 0.47
▸ AURKA O14965 1/20 0.47
▸ CCNT1 O60563 1/20 0.47
▸ JAK2 O60674 1/20 0.47
▸ RET P07949 1/20 0.47
▸ MET P08581 1/20 0.47
▸ ROS1 P08922 1/20 0.47
▸ PDGFRB P09619 1/20 0.47
▸ KIT P10721 1/20 0.47
▸ PIM1 P11309 1/20 0.47
▸ PDGFRA P16234 1/20 0.47
▸ FER P16591 1/20 0.47
▸ EPHA1 P21709 1/20 0.47
▸ MAPK3 P27361 1/20 0.47
▸ EPHB2 P29323 1/20 0.47
▸ AXL P30530 1/20 0.47

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30860284 0.89 EGFR (0.62) EGFRINSRIGF1RALKCHEK1
SCHEMBL26906589 0.87 EGFR (0.55) EGFRINSRIGF1RALKMET
SCHEMBL25450115 0.87 EGFR (0.57) EGFRINSRIGF1RALKCHEK1
SCHEMBL24179375 0.86 EGFR (0.58) EGFRINSRIGF1RALKCHEK1
SCHEMBL26906830 0.86 EGFR (0.56) EGFRINSRIGF1RALKMET
SCHEMBL25450065 0.85 EGFR (0.56) EGFRINSRIGF1RALKCHEK1
SCHEMBL26906768 0.85 EGFR (0.58) EGFRINSRIGF1RALKMET
SCHEMBL30860334 0.85 EGFR (0.52) EGFRINSRIGF1RALKMET
SCHEMBL30860743 0.81 EGFR (0.65) EGFRINSRIGF1RALKCHEK1
SCHEMBL30860373 0.81 EGFR (0.63) EGFRINSRIGF1RALKCHEK1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024072075-A1 PYRIMIDINE DERIVATIVE HAVING PROTEIN KINASE INHIBITORY ACTIVITY, AND THERAPEUTIC PHARMACEUTICAL COMPOSITION COMPRISING SAME 주식회사 테라펙스 2024-04-04 — — WO disclosed
Send feedback